An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The ULs for each nutrient remain unchanged from the 3rd edition values: 100 mg/day for vitamin B6, 1,000 mg (1,600 IU)/day ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

SURPASS-2 was an open label, 40-week, phase-3 trial which randomized patients to receive once-weekly injections of Mounjaro at a dose of 5 mg, 10 mg, or 15 mg, or Ozempic at a dose of 1 mg.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.